Comparative Effectiveness of Ultrasound-Guided Intratendinous Prolotherapy Injection with Conventional Treatment to Treat Focal Supraspinatus Tendinosis

Table 1

Comparison of DASH, pain, and difficulty to sleep between the prolotherapy group () and the control group () at baseline and at 12 weeks.

	Mean		Post-pre- improvement (%)	value (Fisher’s exact test)
	Baseline	12 weeks
DASH score
Prolotherapy	60.14	43.89	27.0%	0.364
Control	56.86	46.68	17.9%
Pain score
Prolotherapy	3.29	1.86	43.5%	0.247
Control	3.20	2.40	25.0%
Difficulty to sleep score
Prolotherapy	3.29	2.15	34.6%	0.027
Control	2.20	2.60	−18.2%

Level of significant set at .